首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >QUANTIFICATION OF THE ANTIBODY DRUG CONJUGATE, TRASTUZUMAB EMTANSINE, AND THE MONOCLONAL ANTIBODY, TRASTUZUMAB, IN PLASMA USING A GENERIC KIT-BASED APPROACH
【24h】

QUANTIFICATION OF THE ANTIBODY DRUG CONJUGATE, TRASTUZUMAB EMTANSINE, AND THE MONOCLONAL ANTIBODY, TRASTUZUMAB, IN PLASMA USING A GENERIC KIT-BASED APPROACH

机译:使用通用套件的方法定量抗体药物缀合物,曲妥珠单抗蛋白和单克隆抗体,曲妥珠单抗,血浆中的血浆

获取原文

摘要

Using a generic kit-based approach, total antibody quantification of a mAb therapeutic (Trastuzuamb) and ADC (Trastuzumab Emtansine) was achieved with successful detection and identification of miscleavage peptides. Quantification limits of 0.5-1 μg/mL were achieved, while maintaining excellent linearity, precision and accuracy. The universal, kit-based approach allows scientists to achieve high sensitivity with a simple step-wise protocol and standardized, pre-measured reagents, ensuring both the sensitivity and reproducibility required in discovery studies to make time sensitive and critical project decisions.
机译:使用基于通用的试剂盒的方法,通过成功检测和鉴定切片肽,实现了MAB治疗(曲抗uamm)和ADC(曲妥珠珠胺Omtansine)的总抗体定量。实现了0.5-1μg/ ml的定量限制,同时保持优异的线性度,精度和精度。基于套件的套件的方法使科学家能够通过简单的迈出方案和标准化,预测量的试剂来实现高灵敏度,确保发现研究中所需的灵敏度和再现性,以制定时间敏感和关键的项目决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号